CHEFA is proud to highlight the impact of its $61,200 grant to Middlesex Hospital to support its implementation of Transpara Breast AI — an advanced, artificial intelligence technology that significantly increases breast cancer detection rates and strengthens diagnostic accuracy.
Over the one‑year grant period, more than 26,000 patients received screening and diagnostic mammograms enhanced by Transpara AI. The hospital reported a 21% increase in overall cancer detection rates, far exceeding the original expectation of a 5–10% improvement. This increase reflects the tool’s ability to identify smaller and more subtle cancers that may otherwise be missed in standard mammography interpretation.
Middlesex Hospital documented a cancer detection rate of 49.5 per 1,000 screens among cases categorized as elevated risk — compared to the standard 5–7 cancers detected per 1,000 using 3D mammography alone. This increase demonstrates the profound role AI can play in early cancer detection, especially for individuals at higher risk.
Transpara AI also contributed to a meaningful decrease in patient recall rates. Historically, Middlesex Hospital’s recall rate has averaged around 15%. Following implementation of the new technology, the rate fell to 11.9%, the lowest in five years. Fewer recalls mean fewer unnecessary follow‑up appointments, reduced patient anxiety, and more efficient use of clinical resources.
By supporting strategic, innovative healthcare technology, CHEFA continues to empower Connecticut’s healthcare providers to deliver earlier diagnoses, more accurate results, and improved patient outcomes — ensuring that individuals across the region benefit from the most advanced tools available.